Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	11.90B -35.6%
Revenue (ttm)	4.20B +0.6%
Net Income	1.04B -8.4%
EPS	12.26 -8.6%
Shares Out	84.72M
PE Ratio	11.46
Forward PE	9.78
Dividend	7.50 (5.64%)
Ex-Dividend Date	Mar 26, 2026

Volume	519,075
Average Volume	258,012
Open	135.00
Previous Close	133.00
Day's Range	134.50 - 141.00
52-Week Range	129.50 - 244.50
Beta	0.35
RSI	50.60
Earnings Date	Mar 10, 2026

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2024, TPEX:3218's revenue was 4.23 billion, an increase of 3.58% compared to the previous year's 4.08 billion. Earnings were 1.06 billion, an increase of 1.88%.